• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于超出全直肠系膜切除平面的复发性和原发性直肠癌多学科管理的共识声明。

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.

出版信息

Br J Surg. 2013 Jul;100(8):E1-33. doi: 10.1002/bjs.9192_1.

DOI:10.1002/bjs.9192_1
PMID:23901427
Abstract

BACKGROUND

The management of primary rectal cancer beyond total mesorectal excision planes (PRC-bTME) and recurrent rectal cancer (RRC) is challenging. There is global variation in standards and no guidelines exist. To achieve cure most patients require extended, multivisceral, exenterative surgery, beyond conventional total mesorectal excision planes. The aim of the Beyond TME Group was to achieve consensus on the definitions and principles of management, and to identify areas of research priority.

METHODS

Delphi methodology was used to achieve consensus. The Group consisted of invited experts from surgery, radiology, oncology and pathology. The process included two international dedicated discussion conferences, formal feedback, three rounds of editing and two rounds of anonymized web-based voting. Consensus was achieved with more than 80 per cent agreement; less than 80 per cent agreement indicated low consensus. During conferences held in September 2011 and March 2012, open discussion took place on areas in which there is a low level of consensus.

RESULTS

The final consensus document included 51 voted statements, making recommendations on ten key areas of PRC-bTME and RRC. Consensus agreement was achieved on the recommendations of 49 statements, with 34 achieving consensus in over 95 per cent. The lowest level of consensus obtained was 76 per cent. There was clear identification of the need for referral to a specialist multidisciplinary team for diagnosis, assessment and further management.

CONCLUSION

The consensus process has provided guidance for the management of patients with PRC-bTME or RRC, taking into account global variations in surgical techniques and technology. It has further identified areas of research priority.

摘要

背景

原发直肠癌超出全直肠系膜切除术(PRC-bTME)和复发性直肠癌(RRC)的治疗具有挑战性。标准在全球范围内存在差异,目前尚无指南。为了实现治愈,大多数患者需要进行超出传统全直肠系膜切除范围的广泛、多脏器、根治性手术。Beyond TME 小组的目的是就管理的定义和原则达成共识,并确定研究重点领域。

方法

采用 Delphi 方法达成共识。该小组由来自外科、放射科、肿瘤学和病理学的特邀专家组成。该过程包括两次国际专题讨论会议、正式反馈、三轮编辑和两轮匿名在线投票。达成共识的标准是超过 80%的同意;低于 80%的同意表示低共识。在 2011 年 9 月和 2012 年 3 月举行的会议上,就共识水平较低的领域进行了公开讨论。

结果

最终的共识文件包括 51 项投票声明,对 PRC-bTME 和 RRC 的十个关键领域提出了建议。49 项建议达成共识,其中 34 项的共识率超过 95%。达成共识的最低比例为 76%。明确需要向专门的多学科团队转诊,以进行诊断、评估和进一步治疗。

结论

共识过程考虑到手术技术和技术的全球差异,为 PRC-bTME 或 RRC 患者的治疗提供了指导,并进一步确定了研究重点领域。

相似文献

1
Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.关于超出全直肠系膜切除平面的复发性和原发性直肠癌多学科管理的共识声明。
Br J Surg. 2013 Jul;100(8):E1-33. doi: 10.1002/bjs.9192_1.
2
Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.局部复发和原发性直肠癌患者的多学科综合管理共识声明:超出全直肠系膜切除平面。
Br J Surg. 2013 Jul;100(8):1009-14. doi: 10.1002/bjs.9192.
3
Techniques and Outcome of Surgery for Locally Advanced and Local Recurrent Rectal Cancer.局部进展期及局部复发性直肠癌的手术技术与治疗结果
Clin Oncol (R Coll Radiol). 2016 Feb;28(2):103-115. doi: 10.1016/j.clon.2015.11.006. Epub 2015 Dec 9.
4
[Chinese expert consensus on the pelvic exenteration for primary rectal cancer beyond total mesorectal excision planes and locally recurrent rectal cancer (2023 edition)].《直肠癌全直肠系膜切除平面外原发性直肠癌及局部复发性直肠癌盆腔脏器切除术中国专家共识(2023年版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Jan 25;26(1):16-26. doi: 10.3760/cma.j.cn441530-20221114-00467.
5
Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.法国与澳大利亚之间比较直肠癌根治术(TME)以外的原发性直肠癌及局部复发性直肠癌治疗管理的基准试验(PelviCare试验):原理与设计
BMC Cancer. 2016 Apr 4;16:262. doi: 10.1186/s12885-016-2286-1.
6
Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era.全直肠系膜切除时代后 T4 期直肠癌手术后的预后因素和失败模式。
Br J Surg. 2019 Nov;106(12):1685-1696. doi: 10.1002/bjs.11242. Epub 2019 Jul 24.
7
Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).直肠癌外科治疗临床实践指南:希腊医学肿瘤学家协会(HeSMO)共识声明
Ann Gastroenterol. 2016 Apr-Jun;29(2):103-26. doi: 10.20524/aog.2016.0003.
8
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.EURECCA 结直肠:多学科管理:欧洲共识会议结肠和直肠。
Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048. Epub 2013 Oct 31.
9
Evolving role of neoadjuvant therapy in rectal cancer.新辅助治疗在直肠癌中的作用演变。
Curr Treat Options Oncol. 2013 Sep;14(3):350-64. doi: 10.1007/s11864-013-0242-8.
10
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.EURECCA 结直肠:改善欧洲结直肠癌患者治疗的多学科使命声明。
Eur J Cancer. 2013 Sep;49(13):2784-90. doi: 10.1016/j.ejca.2013.04.032. Epub 2013 Jun 14.

引用本文的文献

1
Robotic Beyond Total Mesorectal Excision (bTME) for locally advanced and recurrent anorectal cancer: a systematic review.机器人辅助超全直肠系膜切除术(bTME)治疗局部晚期和复发性肛管直肠癌:一项系统评价
J Robot Surg. 2025 Jul 16;19(1):397. doi: 10.1007/s11701-025-02573-1.
2
Benefit of laparoscopic two-team transanal beyond total mesorectal excision for advanced and recurrent rectal cancer with invasion: a retrospective study compared with conventional laparoscopic approach.腹腔镜两组经肛门手术超越全直肠系膜切除术治疗伴有侵犯的晚期和复发性直肠癌的益处:一项与传统腹腔镜手术方法比较的回顾性研究
Tech Coloproctol. 2025 May 23;29(1):120. doi: 10.1007/s10151-025-03158-8.
3
Simultaneous robotic-assisted prostatectomy and rectal resection: a systematic review.
同步机器人辅助前列腺切除术和直肠切除术:一项系统评价
J Robot Surg. 2025 May 23;19(1):229. doi: 10.1007/s11701-025-02395-1.
4
Clinical calculator based on clinicopathological characteristics predicts local recurrence and overall survival following radical resection of stage II-III colorectal cancer.基于临床病理特征的临床计算器可预测II-III期结直肠癌根治术后的局部复发和总生存期。
Front Oncol. 2025 Feb 5;15:1494255. doi: 10.3389/fonc.2025.1494255. eCollection 2025.
5
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology.ELECTRA试验:低容量高复杂性外科肿瘤学双盲、随机、对照临床试验开发与实施中的当代挑战应对方法
Cancers (Basel). 2025 Jan 21;17(3):341. doi: 10.3390/cancers17030341.
6
Advances in beyond total mesorectal excision surgery: Behind the scenes.全直肠系膜切除术后手术进展:幕后故事
World J Gastrointest Surg. 2024 Nov 27;16(11):3381-3384. doi: 10.4240/wjgs.v16.i11.3381.
7
Retrospective study of combined pelvic exenteration in the treatment of primary and recurrent pelvic malignant tumors.盆腔脏器联合切除术治疗原发性及复发性盆腔恶性肿瘤的回顾性研究
J Gastrointest Oncol. 2024 Feb 29;15(1):299-311. doi: 10.21037/jgo-23-973. Epub 2024 Feb 23.
8
Robotic beyond total mesorectal excision (TME) for locally advanced or recurrent rectal cancer: a systematic review protocol.机器人辅助超全直肠系膜切除术治疗局部晚期或复发性直肠癌:一项系统评价方案
BMJ Open. 2024 Jan 25;14(1):e080043. doi: 10.1136/bmjopen-2023-080043.
9
Redo Pelvic Surgery and Combined Metastectomy for Locally Recurrent Rectal Cancer with Known Oligometastatic Disease: A Multicentre Review.针对已知寡转移疾病的局部复发性直肠癌进行盆腔再次手术及联合转移灶切除术:一项多中心综述
Cancers (Basel). 2023 Sep 8;15(18):4469. doi: 10.3390/cancers15184469.
10
Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study.局部复发性直肠癌预后列线图的构建与验证:一项基于人群的研究
J Gastrointest Oncol. 2023 Jun 30;14(3):1293-1306. doi: 10.21037/jgo-22-995. Epub 2023 Apr 20.